Coag-Sense™ Prothrombin Time (PT)/INR Monitoring System Professional User’s Manual
Page 4 For In Vitro Diagnostic Use CoaguSense, Inc.
The Coag-Sense™Prothrombin Time (PT)/INR Monitoring
System
Intended Use
The Coag-Sense Prothrombin Time (PT)/INR Monitoring System
is an in vitro diagnostic device that provides quantitative
prothrombin time (PT) results, expressed in seconds and INR
units. It uses fresh capillary whole blood. It is intended for use
by health care professionals at the point of care to monitor
patients who are on warfarin-type (coumarin) anticoagulation
therapy. The device is not intended to be used for screening
purposes.
The Coag-Sense PT/INR System may be used for multiple-
patient testing in a professional healthcare setting.
Anticoagulation Medication
Oral anticoagulation medications, also known as blood thinners,
are typically prescribed to patients to avoid unwanted clots. The
patient’s blood clotting time must be monitored to ensure that
their dosage is correct.
Oral anti-coagulation medication is prescribed to patients with
acute and chronic conditions including, but not limited to:
congestive heart failure, atrial fibrillation, prosthetic heart valve,
myocardial infarction, joint replacement, deep vein thrombosis,
pulmonary embolism, thrombotic stroke, coronary artery disease,
venous thromboembolism and cancer.
Blood-clotting Time
The rate at which blood clots is measured in units is called
International Normalized Ratio (INR). It is very important for
patients to stay within their individual target INR range. If the INR